Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Appointed COO

Hillstream BioPharma Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
09/29/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/18/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
08/11/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/17/2023 8-K Changes in Registrant's Certifying Accountant  Interactive Data
07/11/2023 8-K Quarterly results
06/16/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
05/16/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
04/27/2023 FWP Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
04/27/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
03/27/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/17/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
03/16/2023 10-K Annual Report for the period ended December 31, 2022
03/13/2023 4/A MILBY RANDY (CEO) has filed a Form 4 on Hillstream BioPharma Inc.
Txns: Granted 515,127 options to buy @ $0.39, valued at $200.9k
02/14/2023 8-K Other Events  Interactive Data
02/07/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
01/04/2023 4 MILBY RANDY (CEO) has filed a Form 4 on Hillstream BioPharma Inc.
Txns: Granted 621,795 options to buy @ $0.39, valued at $242.5k
10/28/2022 8-K Quarterly results
08/11/2022 10-Q Quarterly Report for the period ended June 30, 2022
07/18/2022 4 Appajosyula Sireesh (Director) has filed a Form 4 on Hillstream BioPharma Inc.
Txns: Gifted 75,757 shares @ $0
Gifted 7,576 shares @ $0
06/23/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
06/21/2022 4 MILBY RANDY (CEO) has filed a Form 4 on Hillstream BioPharma Inc.
Txns: Bought 500 shares @ $0.7799, valued at $390
06/17/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
06/17/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
06/07/2022 4 MILBY RANDY (CEO) has filed a Form 4 on Hillstream BioPharma Inc.
Txns: Bought 234 shares @ $0.6849, valued at $160.3
Bought 100 shares @ $0.6701, valued at $67
Bought 66 shares @ $0.6701, valued at $44.2
Bought 500 shares @ $0.6999, valued at $350
06/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/25/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/13/2022 10-Q Quarterly Report for the period ended March 31, 2022
04/19/2022 4 MILBY RANDY (CEO) has filed a Form 4 on Hillstream BioPharma Inc.
Txns: Exercised (in-or-at-the-money) 7,575 options to buy @ $0.314, valued at $2.4k
Exercised (in-or-at-the-money) 189,393 options to buy @ $0.079, valued at $15k
Exercised (in-or-at-the-money) 28,408 options to buy @ $0.079, valued at $2.2k
04/19/2022 3/A MILBY RANDY (CEO) has filed a Form 3/A on Hillstream BioPharma Inc.
04/01/2022 10-K Annual Report for the period ended December 31, 2021
04/01/2022 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
03/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy